genedrive plc (LON:GDR – Get Free Report)’s stock price dropped 10% during mid-day trading on Friday . The stock traded as low as GBX 0.98 and last traded at GBX 1.08. Approximately 10,208,916 shares were traded during trading, an increase of 65% from the average daily volume of 6,194,629 shares. The stock had previously closed at GBX 1.20.
genedrive Trading Down 10.0%
The company has a debt-to-equity ratio of -120.48, a current ratio of 0.99 and a quick ratio of 5.52. The company has a market cap of £17.34 million, a price-to-earnings ratio of -1.37 and a beta of 0.99. The business’s 50-day simple moving average is GBX 1.22 and its 200-day simple moving average is GBX 1.08.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
See Also
- Five stocks we like better than genedrive
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
